The 2021 International Protein Synthesis and Peptide Conference was successfully held in Pingshan, Shenzhen on April 3-4. The conference provided an occasion for experts and scholars in the field of protein and peptide science to exchange on cutting-edge questions, development trends and latest discovery.

The International Protein Synthesis and Peptide Conference (IPSPC) was initiated by famous scientists in China and was held for three sessions. The 2021 IPSPC, hosted by Pingshan Translational Medicine Center (PTMC) and co-hosted by Shenzhen Hongke Biotechnology Co., Ltd., is the fourth gathering of this conference. Themed on “Biochemical Technology To Advance Human Civilization”, the 2021 IPSPC focused around research areas in the structure, function and synthesis of peptide and protein, peptide-based drug discovery, proteomics and metabolomics and immunotherapy.

Nearly 40 experts and scholars from 26 universities, research institutions and hospitals were invited to attend the conference. Academic seminars, open discussions, and webinars were organized to promote scientific exchanges for the development of peptide and protein science.

At the seminar session, 24 experts and scholars shared their latest research with the conferees. Professor Tian Changlin from the University of Science and Technology of China introduced his new discoveries on peptide drug through video.

PTMC hosted the 2021 IPSPC in an effort to create a high-level academic exchange platform for peptide and protein science and to advance China’s peptide and protein research as well as relevant industrial innovation.